JPMORGAN MID CAP INV TRUST PLC

Director's Dealing • Jan 4, 2022

National Storage Mechanism | Additional information

RNS Number : 3743X

JPMorgan Mid Cap Invest Trust PLC

04 January 2022

JPMORGAN MID CAP

INVESTMENT TRUST PLC

(the 'Company')

Compliance with Market Abuse Regulation

Closed Period Notification

Legal Entity Identifier: 549300QED7IGEP4UFN49

Information disclosed in accordance with Market Abuse Regulation Article 19, paragraph 11

The Company announces that it is satisfied that all inside information which the Directors and the Company may have in the period leading up to the announcement of its results for the half year ended 31st December 2021 has previously been, and will continue to be, notified via a regulatory information service. Therefore the Company is not prohibited from dealing in its own securities.

The mandatory closed period under the Market Abuse Regulation will commence on 24th January 2022 and will last until the results in respect of the half year ended 31st December 2021 are published on or around 4th March 2022.      

If in the period leading up to the announcement of the half year results the Directors of the Company come into the possession of any inside information, this will be notified to a RIS before any such transactions are undertaken.

JPMorgan Funds Limited - Secretary

4th January 2022

For further information, please contact:

Alison Vincent

JPMorgan Funds Limited                                            

020 7742 4000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

CMCBKQBQDBKDKDK